Insider trades

Vuong Trieu, Chairman of Oncotelic Therapeutics OTLC, has filed 19 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $27.1K. The latest trade was on 06/24.

Vuong Trieu

Chairman and CEO
First filing
23/05/02
Trades
21 trades
Buys / sales
19 / 0
12-month net buying
$27.1K
Last trade
06/24

Trading activity

Transactions

Trade type
OTLC
Open-market buy06/22–06/2406/24255,000 sh3 trades$0.05avg.$12,750+0.3%
OTLC
Open-market buy06/15–06/1706/17335,759 sh2 trades$0.04avg.$14,390.36+0.4%
OTLC
Open-market buy25/07/08–25/07/1025/07/10198,737 sh3 trades$0.01avg.$1,987.37+0.2%
OTLC
Open-market buy25/01/29–25/01/3125/01/31346,844 sh3 trades$0.03avg.$10,405.32+0.4%
Open-market buy24/11/2224/11/26298,499 sh$0.03$8,954.97+0.3%
Open-market buy24/08/2324/08/27500,000 sh$0.02$10,000+0.5%
OTLC
Open-market buy23/06/28–23/06/2923/06/30500,000 sh2 trades$0.02avg.$10,750+0.5%
Open-market buy23/06/1623/06/20100,000 sh$0.03$3,000+0.1%
Open-market buy23/06/1423/06/16400,000 sh$0.03$12,000+0.4%
Open-market buy23/05/2623/05/31126,888 sh$0.03$3,806.64+0.1%
Open-market buy23/05/0223/05/02100,000 sh$0.05$5,000+0.1%